Equillium COO sells 95,833 shares in plan trade
Equillium, Inc. senior vice president and COO Christine Zedelmayer reported a set of option exercises paired with open-market sales of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Equillium, Inc. senior vice president and COO Christine Zedelmayer reported a set of option exercises paired with open-market sales of common stock. She exercised employee stock options to acquire 95,833 shares at strike prices between $0.73 and $0.785 per share, then sold 95,833 shares at market prices around the high $2 range. After these transactions, she directly holds 62,586 shares of Equillium common stock. A footnote states that at least part of the sales were made under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 7,292 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) | 48,512 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) | 14,583 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) | 15,625 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,292 | $0.73 | $5K |
| Exercise | Common Stock | 48,512 | $0.77 | $37K |
| Sale | Common Stock | 55,604 | $2.70 | $150K |
| Sale | Common Stock | 200 | $2.71 | $542.00 |
| Exercise | Common Stock | 14,583 | $0.785 | $11K |
| Exercise | Common Stock | 15,625 | $0.785 | $12K |
| Sale | Common Stock | 30,208 | $2.98 | $90K |
| Exercise | Employee Stock Option (right to buy) | 9,821 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,821 | $0.77 | $8K |
| Sale | Common Stock | 9,821 | $2.70 | $27K |
Footnotes (3)
- F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.97 to $3.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
weighted average price financial
Employee Stock Option (right to buy) financial
derivative security financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Equillium (EQ) executive Christine Zedelmayer report in this Form 4?
Were Christine Zedelmayer’s Equillium (EQ) stock sales pre-planned under a Rule 10b5-1 plan?
What option exercises did Christine Zedelmayer report for Equillium (EQ)?
AI-generated analysis. How Rhea-AI works. Not financial advice.